Developing new antibiotics by targeting bacterial signaling pathways
Targeting Bacterial Signaling Cascades as a Novel Antibiotic Strategy
This study is looking at how harmful bacteria, like those that cause tuberculosis and MRSA, talk to each other and react to their surroundings, with the goal of finding new ways to create antibiotics that can help people who are struggling with infections that don't respond to current treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | VA Eastern Colorado Health Care System NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-10948916 on NIH RePORTER |
What this research studies
This research focuses on understanding how certain bacteria, particularly those that cause serious infections like tuberculosis and MRSA, communicate and respond to their environment. By investigating specific proteins involved in bacterial signaling, the research aims to identify new targets for antibiotic development. This approach is crucial as many current antibiotics are becoming ineffective due to rising drug resistance. Patients may benefit from new treatments that can effectively combat these resistant infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from infections caused by antibiotic-resistant bacteria, such as MRSA or multidrug-resistant tuberculosis.
Not a fit: Patients with infections caused by bacteria that are not resistant to current antibiotics may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of novel antibiotics that effectively treat infections caused by antibiotic-resistant bacteria.
How similar studies have performed: While the approach of targeting bacterial signaling pathways is relatively novel, there is growing interest in this area, and preliminary studies have shown promise in developing new antibiotic strategies.
Where this research is happening
Aurora, UNITED STATES
- VA Eastern Colorado Health Care System — Aurora, United States (Active)
Researchers
- Principal investigator: Wlodarchak, Nathan J — VA Eastern Colorado Health Care System
- Study coordinator: Wlodarchak, Nathan J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.